Trial · NCT01808144
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Blood creatinine increased | Investigations | Lesinurad 200 mg + Febuxostat 80 mg | 11 | 97 | 14 |
| other | Blood creatinine increased | Investigations | Lesinurad 400 mg + Febuxostat 80 mg | 13 | 99 | 15 |
| other | Nasopharyngitis | Infections and infestations | Lesinurad 200 mg + Febuxostat 80 mg | 6 | 97 | 6 |
| other | Nasopharyngitis | Infections and infestations | Lesinurad 400 mg + Febuxostat 80 mg | 14 | 99 | 20 |
| other | Hypertension | Vascular disorders | Lesinurad 200 mg + Febuxostat 80 mg | 6 | 97 | 6 |
| other | Hypertension | Vascular disorders | Lesinurad 400 mg + Febuxostat 80 mg | 10 | 99 | 10 |
| other | Bronchitis | Infections and infestations | Lesinurad 200 mg + Febuxostat 80 mg | 11 | 97 | 12 |
| other | Bronchitis | Infections and infestations | Lesinurad 400 mg + Febuxostat 80 mg | 4 | 99 | 5 |
| other | Upper respiratory tract infection | Infections and infestations | Lesinurad 200 mg + Febuxostat 80 mg | 8 | 97 | 10 |
| other | Upper respiratory tract infection | Infections and infestations | Lesinurad 400 mg + Febuxostat 80 mg | 6 | 99 | 9 |
| other | Sinusitis | Infections and infestations | Lesinurad 200 mg + Febuxostat 80 mg | 8 | 97 | 8 |
| other | Sinusitis | Infections and infestations | Lesinurad 400 mg + Febuxostat 80 mg | 5 | 99 | 5 |
| other | Headache | Nervous system disorders | Lesinurad 200 mg + Febuxostat 80 mg | 5 | 97 | 6 |
| other | Headache | Nervous system disorders | Lesinurad 400 mg + Febuxostat 80 mg | 7 | 99 | 9 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Lesinurad 200 mg + Febuxostat 80 mg | 6 | 97 | 10 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Lesinurad 400 mg + Febuxostat 80 mg | 5 | 99 | 5 |
| other | Urinary tract infection | Infections and infestations | Lesinurad 200 mg + Febuxostat 80 mg | 6 | 97 | 11 |
| other | Urinary tract infection | Infections and infestations | Lesinurad 400 mg + Febuxostat 80 mg | 5 | 99 | 5 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Lesinurad 200 mg + Febuxostat 80 mg | 4 | 97 | 5 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Lesinurad 400 mg + Febuxostat 80 mg | 6 | 99 | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01808144/events